Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Mild Alzheimer Disease: early-phase trial registry

3 of 4 indexed Mild Alzheimer Disease trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count

Mild Alzheimer Disease: 4 US clinical trials tracked, 3 recruiting.

Mild Alzheimer Disease is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Indivi, running 1 of these trials.

Enrollment posture brief

Registry condition mild-alzheimer-disease

OPEN 3 | RECR 75% | LATE 0 | EARLY 2 | RANK #4115 | SPON 1

Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)

Ablation80%ACL Reconstruction80%Mild Alzheimer Disease (this)75%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Mild Alzheimer Disease

Mild Alzheimer Disease lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Mild Alzheimer Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Mild Alzheimer Disease is recruiting above its size-band peers.

    3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11Phase 21

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1

Named interventions

Most-linked intervention names on Mild Alzheimer Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

home-based self-administered interactive exercise Device
1 trials
Siponimod Drug
1 trials
Nicotinamide riboside Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Mild Alzheimer Disease trials. A trial with sites in several states counts in each.

Massachusetts 2 trials
Texas 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Mild Alzheimer Disease page

4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 3 Mild Alzheimer Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Indivi sponsors the most Mild Alzheimer Disease trials on record, review their full trial history before evaluating a specific study. See Indivi's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Mild Alzheimer Disease condition card totals 4 registered trials; most-linked intervention home-based self-administered interactive exercise; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.